Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis - PubMed (original) (raw)
Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis
Peijun Tian et al. J Nutr Biochem. 2019 Apr.
Abstract
Depression disorder is rapidly advancing worldwide, and therapeutic strategy through gut-brain axis has been proven to be effective in the treatment. Here we studied the effect of lactic acid bacteria (LAB) treatment on depression. C57BL/6J mice were administered with LAB during a 5-week chronic unpredictable mild stress. Bifidobacterium longum subsp. infantis E41 and Bifidobacterium breve M2CF22M7, which improved the expression of Tph1 and secretion of 5-hydroxytryptophan (5-HTP) in RIN14B cells, significantly reduced depressive behaviors of mice in the forced swim test, sucrose preference test and step-down test, as well as increased the level of 5-hydroxytryptamine and brain-derived neurotrophic factor concentration in brain. Besides, M2CF22M7 reduced the serum corticosterone level. E41 increased cecal butyrate level, which significantly and positively correlated with some depression-related indexes. Using 16S rRNA-amplicon sequencing of faces, E41 and M2CF22M7 were found to improve the chronic-stress-induced microbial dysbiosis. They also normalized the host's pathways involving metabolism and gene information processing. These results indicate that Bifidobacterium E41 and M2CF22M7 have an antidepressant effect in mice partly in a 5-HTP dependent and microbiota-regulating manner. Nurturing the gut microbiota with these strains may become an emerging therapeutic way for mood disorder.
Keywords: 5-Hydroxytryptophan; Enterochromaffin cell; Gut–brain axis; Microbiota; Short-chain fatty acids.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
- Oral administration of Lactococcus lactis WHH2078 alleviates depressive and anxiety symptoms in mice with induced chronic stress.
Gao K, Farzi A, Ke X, Yu Y, Chen C, Chen S, Yu T, Wang H, Li Y. Gao K, et al. Food Funct. 2022 Jan 24;13(2):957-969. doi: 10.1039/d1fo03723d. Food Funct. 2022. PMID: 35006225 - Ingestion of Bifidobacterium longum subspecies infantis strain CCFM687 regulated emotional behavior and the central BDNF pathway in chronic stress-induced depressive mice through reshaping the gut microbiota.
Tian P, Zou R, Song L, Zhang X, Jiang B, Wang G, Lee YK, Zhao J, Zhang H, Chen W. Tian P, et al. Food Funct. 2019 Nov 1;10(11):7588-7598. doi: 10.1039/c9fo01630a. Epub 2019 Nov 5. Food Funct. 2019. PMID: 31687714 - Corydalis yanhusuo Polysaccharides Ameliorate Chronic Stress-Induced Depression in Mice through Gut Microbiota-Derived Short-Chain Fatty Acid Activation of 5-Hydroxytryptamine Signaling.
Fang Y, Li Y, Liao X, Deng J, Wang Q, Liang J, Yan B. Fang Y, et al. J Med Food. 2023 Dec;26(12):890-901. doi: 10.1089/jmf.2023.K.0050. Epub 2023 Nov 21. J Med Food. 2023. PMID: 38010856 - Bifidobacterium breve Bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouse.
Sushma G, Vaidya B, Sharma S, Devabattula G, Bishnoi M, Kondepudi KK, Sharma SS. Sushma G, et al. Neuropharmacology. 2023 May 15;229:109480. doi: 10.1016/j.neuropharm.2023.109480. Epub 2023 Mar 1. Neuropharmacology. 2023. PMID: 36868402 Review. - Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis.
Farzi A, Hassan AM, Zenz G, Holzer P. Farzi A, et al. Mol Aspects Med. 2019 Apr;66:80-93. doi: 10.1016/j.mam.2018.11.003. Epub 2018 Dec 13. Mol Aspects Med. 2019. PMID: 30513310 Review.
Cited by
- Gut microbial molecules in behavioural and neurodegenerative conditions.
Needham BD, Kaddurah-Daouk R, Mazmanian SK. Needham BD, et al. Nat Rev Neurosci. 2020 Dec;21(12):717-731. doi: 10.1038/s41583-020-00381-0. Epub 2020 Oct 16. Nat Rev Neurosci. 2020. PMID: 33067567 Review. - Efficacy of bifidobacterium-related preparations on depression: the first meta-analysis.
Huang R, Liu Y. Huang R, et al. Front Psychiatry. 2024 Oct 3;15:1463848. doi: 10.3389/fpsyt.2024.1463848. eCollection 2024. Front Psychiatry. 2024. PMID: 39421068 Free PMC article. Review. - Microbiota-Gut-Brain Axis in Major Depression: A New Therapeutic Approach.
Kim IB, Park SC, Kim YK. Kim IB, et al. Adv Exp Med Biol. 2023;1411:209-224. doi: 10.1007/978-981-19-7376-5_10. Adv Exp Med Biol. 2023. PMID: 36949312 Review. - Exploration of associations among dietary tryptophan, microbiome composition and function, and symptom severity in irritable bowel syndrome.
Plantinga AM, Kamp KJ, Wu Q, Chen L, Yoo L, Burr RL, Cain KC, Raftery D, Carnevale Neto F, Badu S, So SY, Savidge T, Shulman RJ, Heitkemper MM. Plantinga AM, et al. Neurogastroenterol Motil. 2023 May;35(5):e14545. doi: 10.1111/nmo.14545. Epub 2023 Feb 13. Neurogastroenterol Motil. 2023. PMID: 36780542 Free PMC article. - Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study.
Fan J, Zhou Y, Meng R, Tang J, Zhu J, Aldrich MC, Cox NJ, Zhu Y, Li Y, Zhou D. Fan J, et al. BMC Med. 2023 Apr 28;21(1):163. doi: 10.1186/s12916-023-02863-1. BMC Med. 2023. PMID: 37118782 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous